Litcius/Paper detail

First-in-human SPECT/CT imaging of [211At]PSMA-5: targeted alpha therapy in a patient with refractory prostate cancer

Tadashi Watabe, Koji Hatano, Sadahiro Naka, Hidetaka Sasaki, Takashi Kamiya, Yoshifumi Shirakami, Atsushi Toyoshima, Jens Cardinale, Frederik L. Giesel, Kayako Isohashi, Norio Nonomura, Noriyuki Tomiyama

2024European Journal of Nuclear Medicine and Molecular Imaging20 citationsDOIOpen Access PDF

Abstract

The version of record of this article, first published in European Journal of Nuclear Medicine and Molecular Imaging, is available online at Publisher’s website: https://doi.org/10.1007/s00259-024-07017-w.

Topics & Concepts

Prostate cancerMedicineRefractory (planetary science)Nuclear medicineRadionuclide therapyRadiologyCancerMedical physicsOncologyInternal medicinePhysicsAstrobiologyRadiopharmaceutical Chemistry and ApplicationsProstate Cancer Treatment and ResearchMedical Imaging Techniques and Applications
First-in-human SPECT/CT imaging of [211At]PSMA-5: targeted alpha therapy in a patient with refractory prostate cancer | Litcius